Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals

Drug Metabolism and Pharmacokinetics

Volumn 26, Issue 5, 2011, Pages 544-547

  Tamaki, Yuichiro ^a   Honda, Masashi ^a   Muroi, Yuka ^a   Arai, Tomio ^b   Sugimura, Haruhiko ^c   Matsubara, Yoichi ^d   Kanno, Shuichi ^e   Ishikawa, Masaaki ^e   Hirasawa, Noriyasu ^a   Hiratsuka, Masahiro ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

CYP2A13; Genetic polymorphism; Japanese; SNP

Indexed keywords

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CYTOCHROME P450 2A13 GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; JAPANESE; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

EID: 80055088430     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-11-SC-033     Document Type: Article

References (11)

1. Koskela, S., Hakkola, J., Hukkanen, J., Pelkonen, O., Sorri, M., Saranen, A., Anttila, S., Fernandez-Salguero, P., Gonzalez, F. and Raunio, H.: Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem. Pharmacol., 57: 1407-1413 (1999).
2. Gu, J., Su, T., Chen, Y., Zhang, Q. Y. and Ding, X.: Expression of biotransformation enzymes in human fetal olfactory mucosa: potential roles in developmental toxicity. Toxicol. Appl. Pharmacol., 165: 158-162 (2000).
3. Su, T., Bao, Z., Zhang, Q. Y., Smith, T. J., Hong, J. Y. and Ding, X.: Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high-efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res., 60: 5074-5079 (2000).
4. Chen, Y., Liu, Y. Q., Su, T., Ren, X., Shi, L., Liu, D., Gu, J., Zhang, Q. Y. and Ding, X.: Immunoblot analysis and immuno-histochemical characterization of CYP2A expression in human olfactory mucosa. Biochem. Pharmacol., 66: 1245-1251 (2003).
5. Ding, X. and Kaminsky, L. S.: Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol., 43: 149-173 (2003).
6. Fernandez-Salguero, P., Hoffman, S. M., Cholerton, S., Mohrenweiser, H., Raunio, H., Rautio, A., Pelkonen, O., Huang, J. D., Evans, W. E., Idle, J. R. and Gonzalez, F. J.: A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am. J. Hum. Genet., 57: 651-660 (1995).
7. Fujieda, M., Yamazaki, H., Kiyotani, K., Muroi, A., Kunitoh, H., Dosaka-Akita, H., Sawamura, Y. and Kamataki, T.: Eighteen novel polymorphisms of the CYP2A13 gene in Japanese. Drug Metab. Pharmacokinet., 18: 86-90 (2003).
8. Zhang, X., Chen, Y., Liu, Y., Ren, X., Zhang, Q. Y., Caggana, M. and Ding, X.: Single nucleotide polymorphisms of the human CYP2A13 gene: evidence for a null allele. Drug Metab. Dispos., 31: 1081-1085 (2003).
9. Cauffiez, C., Lo-Guidice, J. M., Quaranta, S., Aliorge, D., Chevalier, D., Cenee, S., Hamdan, R., Lhermitte, M., Lafitte, J. J., Libersa, C., Colombel, J. F., Stucker, I. and Broly, F.: Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. Biochem. Biophys. Res. Commun., 317: 662-669 (2004).
10. Smith, B. D., Sanders, J. L., Porubsky, P. R., Lushington, G. H., Stout, C. D. and Scott, E. E.: Structure of the human lung cytochrome P450 2A13. J. Biol. Chem., 282: 17306-17313 (2007).
11. Lewis, D. F.: The CYP2 family: models, mutants and interactions. Xenobiotica, 28: 617-661 (1998).